• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BAYLIS MEDICAL COMPANY INC. VERSACROSS ACCESS SOLUTION; INTRODUCER, CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BAYLIS MEDICAL COMPANY INC. VERSACROSS ACCESS SOLUTION; INTRODUCER, CATHETER Back to Search Results
Device Problem Use of Device Problem (1670)
Patient Problems Cardiac Tamponade (2226); Cardiac Perforation (2513); Pericardial Effusion (3271)
Event Date 02/22/2023
Event Type  Injury  
Manufacturer Narrative
It was indicated that the device will not be returned for evaluation.If there is any further relevant information obtained, a supplemental medwatch will be filed.
 
Event Description
It was reported that the patient experienced a cardiac perforation and subsequent pericardial effusion and cardiac tamponade.During a left atrial appendage (laa) closure procedure, during the transseptal crossing, the physician pierced the back wall of the left atrium (la) with the dilator of the versacross sheath.There were no product issues, the physician stated it was operator error.A pericardial effusion with a cardiac tamponade occurred as a result.The procedure was aborted, and the surgeon was called.A window and chest tube were inserted, and the patient was admitted to cardiovascular intensive care unit (cvicu).The patient was stable when they left the operating room (or).
 
Manufacturer Narrative
It was indicated that the device will not be returned for evaluation.If there is any further relevant information obtained, a supplemental medwatch will be filed.
 
Event Description
It was reported that the patient experienced a cardiac perforation and subsequent pericardial effusion and cardiac tamponade.During a left atrial appendage (laa) closure procedure, during the transseptal crossing, the physician pierced the back wall of the left atrium (la) with the dilator of the versacross sheath.There were no product issues, the physician stated it was operator error.A pericardial effusion with a cardiac tamponade occurred as a result.The procedure was aborted, and the surgeon was called.A window and chest tube were inserted, and the patient was admitted to cardiovascular intensive care unit (cvicu).The patient was stable when they left the operating room (or).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VERSACROSS ACCESS SOLUTION
Type of Device
INTRODUCER, CATHETER
Manufacturer (Section D)
BAYLIS MEDICAL COMPANY INC.
5959 trans-canada highway
montreal H4T 1 A1
CA  H4T 1A1
Manufacturer (Section G)
BAYLIS MEDICAL COMPANY INC.
5825 explorer drive
mississauga, on
CA  
Manufacturer Contact
timothy degroot
4100 hamline avenue north
dc a330
saint paul, MN 55112
6515826168
MDR Report Key17606425
MDR Text Key321773784
Report Number2124215-2023-42547
Device Sequence Number1
Product Code DYB
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K183655
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 09/08/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 07/31/2023
Initial Date FDA Received08/23/2023
Supplement Dates Manufacturer Received07/31/2023
Supplement Dates FDA Received09/08/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Life Threatening; Required Intervention;
Patient Age71 YR
-
-